The 13,000 square feet primary and secondary trial packaging unit that expands the active pharmaceutical ingredient (API) site in Morpeth, Humberside, will serve as one stop shop for the drug sector.
The expansion will enable the company to provide everything under one roof– from API development to trial scale manufacture and finally commercial scale production.
The trial centre can manufacture primary packaging for both liquid and solid products. Further, these products are labelled as per trial protocols before being shipped to worldwide trial sites through the dedicated distribution centre.